Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 20, 2012 ) New York, NY -- Advanced Medical Isotope Corporation (ADMD) is already a US-based manufacturer and distributor of medical isotopes and is also developing key technologies that may offer a superior alternative to the current standard of care for battling cancer with nuclear medicine.
In a Thursday report, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, identifies key point for optimism regarding the company and examines its speculative potential as an investment. Full report available at: http://vfcsstockhouse.com/blog/article/-advanced-medical-isotope-corporation-expanded-distribution-and-radiogel-technology-hold-the-keys-to-the-future
Advanced Medical Isotope Corporation (ADMD) has - through key partnerships, expanding distribution channels and the acquisition of a license to a novel cancer-fighting technology - well positioned itself to become a growth player in the field of nuclear medicine, specifically in the field of the production and distribution of medical isotopes. Medical isotopes are used in molecular imaging, therapy, and nuclear medicine to diagnose, manage and treat diseases and are deemed a hot item whenever discussed because of the geopolitical implications of non-nuclear nations attempt to enrich uranium for - ahem - solely medical purposes.
Advanced Medical is one of only a few companies in the United States manufacturing and distributing such isotopes and it's likely that business could quickly hit a growth spurt - not only through the company's own indigenous expansion and distribution efforts, but also because of the growing desire of the medical community in the US to use 'home grown' nuclear materials, not to mention increasing regulation that may force the community to do so anyway.
AMIC already offers a broad variety of isotopes and, as outlined in a recent quarterly report, is looking to expand its 'pipeline' of product offerings for its distribution network of customers that include - but is not limited to - national laboratories, hospitals, research facilities and universities.
Many of the company's isotopes are put to use through molecular imaging, or Positron Emission Tomography (PET), which enables Doctors and medical professionals to identify cancerous condictions well before detection means that search for tumor mass. Some of the radiopharmaceutical products based on the medical isotopes are also used in the early detection of certain cardiovascular indications and, as mentioned above, the demand for such products is growing, not shrinking. According to numbers identified in a recent company presentation and credited to the World Nuclear Association, the use of medical isotopes is growing at an annual rate of 10%.
That places AMIC right in the middle of a potential growth boom.
While production and distribution may encompass the company's core business model, AMIC is moving heavily into the field of treatment, too. The process of placing radioactive "seeds" in or near a cancerous tumor is known as brachytherapy, and AMIC is developing a pipeline based on such technology to augment the already-growing core business plan.
In April, the company acquired a license and numerous relating patents to an injectible radiogel technology that could have a significant impact on the next generation of fighting cancer. Using the radiogel technology doctors could deliver Yttrium-90 "microspheres" directly into cancerous tissue. Because the injectible polymer turns solid and holds the microspheres in place, there is little to no threat of any radiation escaping and damaging surrounding tissue. As described by Dr. Alan Walter, Chair of the AMIC Scientific Committee, in a presentation available on the company's home page, such a technology could be termed as using "smart bullets" to target cancerous cells.
Yttrium-90, in the form of Polymer seeds, is an already-established medical isotope with numerous applications in existing cancer treatment and has demonstrated effectiveness in combating head, neck, liver and prostate cancers, according to an above-linked company presentation. The radiogel application of Yttrium-90 could potentially 'storm the scene' in treating numerous cancer types with the intent of targeting those tumors in the hard-to-get to areas of the body that eliminates surgery as an option.
Both the Polymer seeds and the acquired the radiogel technology significantly boost the diversity of AMIC, offering a targeted path to enter the realm of caner treatment to augment the production, sales and distribution channels of its isotopes.
It's possible, based on previous expectations, that the Brachytherapy pipeline could hit market within a couple of years. At that point AMIC could either move forward with commercialization on its own or out-license the technology to someone else and use that revenue stream of royalties to fund the expansion of the core business.
Shares were up by eight percent on Wednesday, although volume was very light. That said, volume has been picking up significantly over the past few months and has tripled already once this year. Volume has also stormed in after the company's more relevant press releases, indicating that there are investors on the sidelines who either wait to play a quick trade or may be taking a 'wait and see' approach to playing this still-speculative stock.
Should the potential of the AMIC distribution network continue to expand and meet the growing demand for nuclear medicine - and should the polymer seeds and radiogel technology also hit market with momentum - then it's likely that the current ADMD share price could start to move. Currently, shares consistently trade for a few pennies above the twenty cents mark, give or take.
Based on the potential of the developing technology, already-available products and future product offerings, the current ADMD trading levels could serve as an opportune accumulation period to those looking at the risk/reward profile for the future. The current market cap of still under twenty million indicates that many investors are still unconvinced, but when searching for potential payoff picks on the bulletin board stocks, it pays off to be in while the stock is still moving along relatively unnoticed, as the best percentage gains to be had in any run start with being in place before the run starts.
That said, the stock market is risky business and there are no sure things, that's why it's up to each investor to conduct his or her own DD and invest accordingly.
Still a developing story worth monitoring.
Disclosure: No position.
Follow ADMD developments and other small cap stocks at VFCsStockHouse.com
Contact VFC's Stock House: email@example.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, and pharmaceutical and healthcare stocks. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights and opinions into broader-market news. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and make informed and well thought-out investment decisions. For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Ohio woman has long road ahead after rock attack
22 Jul 2014 at 12:42pm
DANVILLE, Pa. (AP) ? Doctors had a simple goal when they first saw how a football-size rock thrown from an interstate overpass in Pennsylvania had shattered Sharon Budd's skull ? to keep her alive.
Dueling rulings: Courts split on health law clash
22 Jul 2014 at 5:27pm
WASHINGTON (AP) ? President Barack Obama's health care law is snarled in another big legal battle, with two federal appeals courts issuing contradictory rulings on a key financing issue within hours of each other Tuesday.
White House: Health subsidies not halted by ruling
22 Jul 2014 at 8:34am
WASHINGTON (AP) ? The White House says health subsidies under the Affordable Care Act will continue to flow for the time being despite a major setback delivered by a federal appeals court.
Survey finds sharp increase in teen use of HGH
22 Jul 2014 at 9:38pm
NEW YORK (AP) ? Experimentation with human growth hormones by America's teens more than doubled in the past year, as more young people looked to drugs to boost their athletic performance and improve their looks, according to a new, large-scale national survey.
Britain plans new laws to prevent female genital mutilation
22 Jul 2014 at 8:00pm
By Kylie MacLellan and Emma Batha LONDON (Reuters) - Britain will introduce new laws to combat female genital mutilation (FGM) including making it compulsory for teachers and health workers to report cases, Prime Minister David Cameron said on Tuesday. "It's absolutely clear what we are trying to achieve... and that is to outlaw the practices of female genital mutilation and childhood and early forced marriage; Around 103,000 women aged between 15 and 49, and another 10,000 girls aged under 15 who have migrated to England and Wales are estimated to have undergone FGM, according to a report on Tuesday from City University London. Cameron said ending FGM and child marriage was a global challenge on a par with eradicating poverty and tackling diseases.
Obama government looks to satisfy religious groups on Obamacare
22 Jul 2014 at 7:43pm
The Obama administration is developing a method for religious organizations opposed to contraception coverage under the Affordable Care Act to opt out of providing the coverage in their health plans without filling out a form. Under President Barack Obama's signature healthcare law, known as Obamacare, employers must provide health insurance policies that cover preventive services for women, including contraception and sterilization. As a result, the Obama administration intends to augment its regulations to provide an alternative way for such religious organizations to provide notification while ensuring that enrollees in plans of such organizations receive separate coverage of contraceptive services.
L.A. Clippers would lose players if Sterling stays: CEO
22 Jul 2014 at 7:15pm
By Eric Kelsey LOS ANGELES (Reuters) - The Los Angeles Clippers could face an exodus of players, sponsors, fans and their coach if embattled owner Donald Sterling is still associated with the team, Richard Parsons, the franchise's interim chief executive, said on Tuesday at a trial over the NBA team's $2 billion sale. Parsons, the former Time Warner CEO who was installed by the NBA to run the Clippers in May, testified that the team would likely lose profitability and its overall value if sponsors, one of its top revenue streams, leave because of Sterling. "We have a bunch of sponsors who are sitting at the edge of the pool and they don't want to go into the water," Parsons told Los Angeles Superior Court a day after failed settlement talks between Sterling, 80, and former Microsoft CEO Steve Ballmer, who won the bidding for the team.
Meningitis diagnosis prompted W.Va. clinic probe
22 Jul 2014 at 5:25pm
CHARLESTON, W.Va. (AP) ? An investigation that found syringes were being reused at a West Virginia pain management clinic ? whose operator had his medical license revoked in Texas ? was triggered after a patient developed bacterial meningitis, a health official said Tuesday.
Seven ex-NFL players appeal concussion settlement
22 Jul 2014 at 5:21pm
(Reuters) - Seven retired National Football League players are appealing a recent settlement between the league and about 5,000 former players stemming from a lawsuit over concussions suffered on the field, court records show. The appeal, filed in the 3rd U.S. Circuit Court of Appeals on Monday, came about two weeks after U.S. District Judge Anita Brody granted preliminary approval to a settlement that removed a $675 million cap on awards to former players who were part of the groundbreaking head injury lawsuit. Attorneys for the plaintiffs say 20,000 retired players could be covered under the agreement. The players filing the appeal said the settlement did not offer enough to those who had yet to see the worst of their symptoms appear, and did not cover all diagnoses suffered by players with head trauma.
Black lung claims by 1,100 coal miners may have been wrongly denied
22 Jul 2014 at 5:16pm
Medical opinions by Dr. Paul Wheeler of Johns Hopkins should be assumed to lack credibility, senators are told at a hearing Tuesday.
U.S. Supreme Court lifts stay of execution for Arizona inmate
22 Jul 2014 at 4:48pm
By David Schwartz PHOENIX (Reuters) - The U.S. Supreme Court on Tuesday vacated a stay of execution for an Arizona inmate who had sued the state demanding more information about the drugs that will be used in the lethal injection procedure he faces. Joseph Wood is one of six death row inmates who sued Arizona last month arguing that secrecy surrounding lethal-injection drugs used in botched executions in Ohio and Oklahoma violated their constitutional rights. He is set to executed at 10 a.m. local time on Wednesday inside the state prison complex in Florence, about 60 miles (97 km) southeast of Phoenix, officials at Arizona's Department of Corrections said.
Latest Obamacare legal knot won't be easy to untangle
22 Jul 2014 at 4:15pm
By David Ingram NEW YORK (Reuters) - U.S. judges have their work cut out for them untangling a legal knot created on Tuesday when two federal appeals courts released conflicting rulings hours apart going to the heart of the role the federal government will play in Obamacare. The latest conservative challenge to President Barack Obama's healthcare overhaul will not necessarily land in the U.S. Supreme Court, although it could end up there as soon as this year if the two lower courts go on disagreeing. At stake is how millions of Americans pay for private health insurance, or if they can afford it at all. The 2010 Affordable Care Act authorized tax credits to subsidize private health insurance.
Obama's veterans agency nominee vows corporate-style discipline
22 Jul 2014 at 4:12pm
By David Lawder WASHINGTON (Reuters) - U.S. President Barack Obama's nominee to fix the Department of Veterans Affairs pledged on Tuesday to bring corporate-style discipline and accountability to the troubled agency plagued by healthcare delays and accusations of mismanagement and fraud. Bob McDonald, the former chief executive officer of Procter & Gamble Co, the world's largest manufacturer of household products, told the Senate Veterans Affairs Committee that he would work to reorganize the VA to deliver care more efficiently to veterans. In a confirmation hearing brimming with corporate management buzzwords, McDonald said he would immerse himself in the VA's operations and devise ways to focus each of the department's 341,000 employees on its core mission of serving veterans. He also told senators he would give them his cellphone number and encouraged them to use it, adding that as P&G's CEO, his phone was turned on "24 hours a day." McDonald, 61, was nominated to replace Eric Shinseki, who resigned as VA secretary in late May amid a scandal over the coverup of delays in scheduling medical appointments at dozens of VA hospitals and clinics across the country.
Colorado judge sets new December 8 trial date in theater massacre case
22 Jul 2014 at 4:02pm
By Keith Coffman CENTENNIAL Colo. (Reuters) - Jury selection in the much-delayed trial of accused movie theater gunman James Holmes will begin on Dec. 8, a Colorado judge said on Tuesday, dismissing objections by the defense who said they needed more time. Arapahoe County District Judge Carlos Samour made the ruling at a pre-trial hearing in Centennial, a suburb of Denver.
Puma says cancer drug meets trial goal, shares soar
22 Jul 2014 at 3:39pm
(Reuters) - Puma Biotechnology Inc said its experimental breast cancer drug met its main goal in a late-stage trial. Puma said on Tuesday it plans to file for marketing approval of neratinib, code named PB272, in the first half of 2015. Adjuvant treatment with the drug showed a statistically significant improvement in disease-free survival of 33 percent versus patients on placebo, according to trial data. Adjuvant treatment, or additional treatment, is given after the primary treatment.